SWOT Analysis for Vaccinex Inc

MACD Crossover Above Signal Line
Price crossing above SMA20 today, and greater than SMA5
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
MACD crossed above signal line previous end of day
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
Biggest Price Gainers from Open
Highest Recovery from 52 Week Low

Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Declining profits every quarter for the past 3 quarters
Stocks Underperforming their Industry Price Change in the Quarter